3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
54
Lung Neoplasms
29
Colorectal Neoplasms
24
Prostatic Neoplasms
23
Colonic Neoplasms
16
Rectal Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Neoplasms
13
Uterine Cervical Neoplasms
12
Lymphoma
11
Urinary Bladder Neoplasms
8
Leukemia
8
Endometrial Neoplasms
8
Depression
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Leukemia, Myeloid, Acute
7
Breast Carcinoma In Situ
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Pain
6
Multiple Myeloma
6
Melanoma
6
Hematologic Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Anxiety Disorders
6
Obesity
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hematopoietic and Lymphatic System Neoplasm
5
Fatigue
5
Burkitt Lymphoma
5
Interventions
Dexamethasone
29
Aprepitant
24
Palonosetron
20
Ondansetron
20
Calcium Dobesilate
13
Olanzapine
12
Granisetron
11
Therapeutics
7
fosaprepitant
6
Doxorubicin
6
Cyclophosphamide
6
dexamethasone acetate
5
netupitant
4
Vincristine
4
dolasetron
3
Yoga
3
Tropisetron
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Metoclopramide
3
Lorazepam
3
Dronabinol
3
Acupressure
3
peppermint oil
2
netupitant, palosentron drug combination
2
ginger extract
2
dexamethasone 21-phosphate
2
Sugars
2
Rituximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Nausea
×
Early Intervention, Educational
×
Clear all
NCT01590147
2018-08-15
SIPS
Wake Forest University Health Sciences
Phase NA
Completed
15 enrolled